AGP Executive Report
Last update: 6 hours agoHepatitis B Trial: Danish researchers are defending a revised study involving 14,000 newborns in Guinea-Bissau, comparing vaccination at birth with the country’s current six-week schedule. The plan has renewed ethical concerns because the birth dose is an established prevention measure and WHO recommends it within 24 hours. Researchers say the revised protocol screens mothers and excludes babies at higher risk of infection, but Guinea-Bissau’s health minister says the government has not authorized the trial. Its status remains disputed despite reported ethics approvals.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.